1. 833. Efficacy and Safety of Long-Acting Cabotegravir + Rilpivirine in Participants with HIV/HCV Co-infection: ATLAS-2M 48-Week Results. (4th December 2021) Authors: D'Amico, Ronald; Benn, Paul; Thiagarajah, Shanker; Ford, Susan L; Birmingham, Eileen; Upadhyay, Ojesh R; Garside, Louise; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Impact of COVID-19 on Cabotegravir Plus Rilpivirine Long-Acting Dosing Across 6 Ongoing Global Phase IIb and III Clinical Trials. (1st October 2022) Authors: Czarnogorski, Maggie; Benn, Paul; McCoig, Cindy; Nwafor, Toyin; Griffith, Sandy; Sutton, Ken; Harrington, Conn; Saggu, Parminder; Yague, Itziar; Williams, Will; Español, Carlos M.; Goodchild, Jessica; Fricker, Jane; Patel, Parul; D'Amico, Ronald Journal: Journal of acquired immune deficiency syndromes Issue: Volume 91:Number 2(2022) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service. Issue 6 (27th April 2012) Authors: Herbert, Sophie; Edwards, Simon; Carrick, Gina; Copas, Andrew; Sandford, Christopher; Amphlett, Marc; Benn, Paul Journal: Sexually transmitted infections Issue: Volume 88:Issue 6(2012) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is the recall of men who have sex with men (MSM) diagnosed as having bacterial sexually transmitted infections (STIs) for re-screening a feasible and effective strategy?. Issue 7 (28th September 2011) Authors: Harte, Derval; Mercey, Danielle; Jarman, Jay; Benn, Paul Journal: Sexually transmitted infections Issue: Volume 87:Issue 7(2011) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LB-8. Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials. (31st December 2020) Authors: D'Amico, Ronald; Benn, Paul; McCoig, Cynthia C; McCoig, Cynthia C; Griffith, Sandy; Hudson, Krischan J; Sutton, Kenneth; Sutton, Kenneth; Harrington, Conn M; Wu, Sterling; Williams, Will; Hove, Kai S; Martin Espanol, Carlos; Fricker, E Jane; Patel, Parul; Margolis, David; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Issue 10267 (19th December 2020) Authors: Overton, Edgar T; Richmond, Gary; Rizzardini, Giuliano; Jaeger, Hans; Orrell, Catherine; Nagimova, Firaya; Bredeek, Fritz; García Deltoro, Miguel; Swindells, Susan; Andrade-Villanueva, Jaime Federico; Wong, Alexander; Khuong-Josses, Marie-Aude; Van Solingen-Ristea, Rodica; van Eygen, Veerle; Crau... Journal: Lancet Issue: Volume 396:Issue 10267(2020) Page Start: 1994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O023 Feasibility study to determine the time taken for NAATs tests to become negative following treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in men and women. (30th June 2016) Authors: Sultan, Binta; Oakland, Clare; Brima, Nataliya; Patel, Hemanti; Copas, Andrew; Benn, Paul; Ison, Cathy; Schembri, Gabriel Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P202 The acceptability of self-sampling at home for Chlamydia trachomatis and Neisseria gonorrhoeae in men and women; results from the feasibility study to determine the time taken for NAATs tests to become negative following treatment for Chlamydia trachomatis and Neisseria gonorrhoeae in men and women. (30th June 2016) Authors: Sultan, Binta; Oakland, Clare; Brima, Nataliya; Patel, Hemi; Schembri, Gabriel; Ison, Cathy; Benn, Paul Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pooled Specimens for HIV RNA Monitoring: Cheaper, but Is It Reliable?. (16th July 2014) Authors: El Bouzidi, Kate; Grant, Paul; Edwards, Simon; Benn, Paul; Pillay, Deenan; Waters, Laura; Nastouli, Eleni Journal: Clinical infectious diseases Issue: Volume 59:Number 9(2014:May 01) Page Start: 1346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study. (June 2014) Authors: Gedela, Keerti; Edwards, Simon G; Benn, Paul; Grant, Alison D Journal: International journal of STD & AIDS Issue: Volume 25:Number 7(2014:Jul.) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗